📣 VC round data is live. Check it out!

Dr. Sulaiman Al Habib Valuation Multiples

Discover revenue and EBITDA valuation multiples for Dr. Sulaiman Al Habib and similar public comparables like IHH Healthcare, Fresenius, Sigma Healthcare, JD Health and more.

Dr. Sulaiman Al Habib Overview

About Dr. Sulaiman Al Habib

Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.


Founded

1993

HQ

Saudi Arabia

Employees

N/A

Website

hmg.com

Financials (LTM)

Revenue: $4B
EBITDA: $930M

EV

$22B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Dr. Sulaiman Al Habib Financials

Dr. Sulaiman Al Habib reported last 12-month revenue of $4B and EBITDA of $930M.

In the same LTM period, Dr. Sulaiman Al Habib generated $1B in gross profit, $930M in EBITDA, and $666M in net income.

Revenue (LTM)


Dr. Sulaiman Al Habib P&L

In the most recent fiscal year, Dr. Sulaiman Al Habib reported revenue of $4B and EBITDA of $947M.

Dr. Sulaiman Al Habib is profitable as of last fiscal year, with gross margin of 31%, EBITDA margin of 26%, and net margin of 18%.

See analyst estimates for Dr. Sulaiman Al Habib
LTMLast FY202320242025202620272028
Revenue$4B$4B$3B$3B$4B
Gross Profit$1B$1B$877M$1B$1B
Gross Margin30%31%34%33%31%
EBITDA$930M$947M$685M$804M$947M
EBITDA Margin24%26%27%27%26%
EBIT Margin19%19%22%21%19%
Net Profit$666M$644M$549M$621M$644M
Net Margin17%18%22%21%18%
Net Debt-$2B---

Financial data powered by Morningstar, Inc.

Dr. Sulaiman Al Habib Stock Performance

Dr. Sulaiman Al Habib has current market cap of $20B, and enterprise value of $22B.

Market Cap Evolution


Dr. Sulaiman Al Habib's stock price is $58.34.

Dr. Sulaiman Al Habib share price decreased by 1.6% in the last 30 days, and by 19.3% in the last year.

Dr. Sulaiman Al Habib has an EPS (earnings per share) of $1.84.

See more trading valuation data for Dr. Sulaiman Al Habib
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$22B$20B-0.1%-1.6%-15.4%-19.3%$1.84

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Dr. Sulaiman Al Habib Valuation Multiples

Dr. Sulaiman Al Habib trades at 5.8x EV/Revenue multiple, and 24.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Dr. Sulaiman Al Habib

EV / Revenue (LTM)


Dr. Sulaiman Al Habib Financial Valuation Multiples

As of June 2, 2026, Dr. Sulaiman Al Habib has market cap of $20B and EV of $22B.

Dr. Sulaiman Al Habib has a P/E ratio of 30.7x.

LTMLast FY202320242025202620272028
EV/Revenue5.8x6.1x8.8x7.4x6.1x
EV/EBITDA24.0x23.6x32.6x27.8x23.6x
EV/EBIT30.5x31.5x39.4x35.1x31.5x
EV/Gross Profit19.1x19.8x25.4x22.2x19.8x
P/E30.7x31.7x37.2x32.9x31.7x
EV/FCF108.1x198.8xn/m(97.0x)198.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Dr. Sulaiman Al Habib Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Dr. Sulaiman Al Habib Margins & Growth Rates

Dr. Sulaiman Al Habib grew revenue by 13% and EBITDA by 5% in the last fiscal year.

In the most recent fiscal year, Dr. Sulaiman Al Habib reported gross margin of 31%, EBITDA margin of 26%, and net margin of 18%.

See estimated margins and future growth rates for Dr. Sulaiman Al Habib

Dr. Sulaiman Al Habib Margins

Last FY202420252026202720282029
Gross Margin31%33%31%30%
EBITDA Margin26%27%26%24%
EBIT Margin19%21%19%19%
Net Margin18%21%18%17%
FCF Margin3%(8%)3%10%

Dr. Sulaiman Al Habib Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth13%18%22%13%
Gross Profit Growth10%15%12%10%
EBITDA Growth5%17%18%5%
EBIT Growth10%12%11%10%
Net Profit Growth9%13%4%9%
FCF Growth251%240%(149%)251%

Data powered by FactSet, Inc. and Morningstar, Inc.

Dr. Sulaiman Al Habib Operational KPIs

Dr. Sulaiman Al Habib's Rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dr. Sulaiman Al Habib's Rule of X is 55% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Dr. Sulaiman Al Habib
LTMLast FY202320242025202620272028
Rule of 4036%37%---
Bessemer Rule of X55%55%---
S&M Expenses to Revenue4%5%1%1%1%
G&A Expenses to Revenue8%8%2%1%2%
Opex to Revenue-11%12%12%11%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Dr. Sulaiman Al Habib Competitors

Dr. Sulaiman Al Habib competitors include IHH Healthcare, Fresenius, Sigma Healthcare, JD Health, Rede D'Or São Luiz, Tenet Healthcare, Aier EYE Hospital Group, Apollo Hospitals, DaVita and BrightSpring Health.

Most Dr. Sulaiman Al Habib public comparables operate across Hospitals & Clinics and Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
IHH Healthcare3.5x3.4x14.6x15.4x
Fresenius1.2x1.2x7.6x7.5x
Sigma Healthcare7.3x3.5x42.7x31.2x
JD Health0.8x0.8x9.6x12.0x
Rede D'Or São Luiz1.5x1.5x7.1x8.1x
Tenet Healthcare1.2x1.2x5.5x5.4x
Aier EYE Hospital Group3.9x3.7x13.3x12.8x
Apollo Hospitals4.9x4.8x30.8x31.9x

This data is available for Pro users. Sign up to see all Dr. Sulaiman Al Habib competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Dr. Sulaiman Al Habib

When was Dr. Sulaiman Al Habib founded?Dr. Sulaiman Al Habib was founded in 1993.
Where is Dr. Sulaiman Al Habib headquartered?Dr. Sulaiman Al Habib is headquartered in Saudi Arabia.
Who is the CEO of Dr. Sulaiman Al Habib?Dr. Sulaiman Al Habib's CEO is Faisal Abdullah Al Nassar.
Is Dr. Sulaiman Al Habib publicly listed?Yes, Dr. Sulaiman Al Habib is a public company listed on Tadawul.
What is the stock symbol of Dr. Sulaiman Al Habib?Dr. Sulaiman Al Habib trades under 4013 ticker.
When did Dr. Sulaiman Al Habib go public?Dr. Sulaiman Al Habib went public in 2020.
Who are competitors of Dr. Sulaiman Al Habib?Dr. Sulaiman Al Habib main competitors include IHH Healthcare, Fresenius, Sigma Healthcare, JD Health, Rede D'Or São Luiz, Tenet Healthcare, Aier EYE Hospital Group, Apollo Hospitals, DaVita, BrightSpring Health.
What is the current market cap of Dr. Sulaiman Al Habib?Dr. Sulaiman Al Habib's current market cap is $20B.
What is the current revenue of Dr. Sulaiman Al Habib?Dr. Sulaiman Al Habib's last 12 months revenue is $4B.
What is the current revenue growth of Dr. Sulaiman Al Habib?Dr. Sulaiman Al Habib revenue growth (NTM/LTM) is 12%.
What is the current EV/Revenue multiple of Dr. Sulaiman Al Habib?Current revenue multiple of Dr. Sulaiman Al Habib is 5.8x.
What is the current EBITDA of Dr. Sulaiman Al Habib?Dr. Sulaiman Al Habib's last 12 months EBITDA is $930M.
What is Dr. Sulaiman Al Habib's EBITDA margin?Dr. Sulaiman Al Habib's last 12 months EBITDA margin is 24%.
What is the current EV/EBITDA multiple of Dr. Sulaiman Al Habib?Current EBITDA multiple of Dr. Sulaiman Al Habib is 24.0x.
What is the current FCF of Dr. Sulaiman Al Habib?Dr. Sulaiman Al Habib's last 12 months FCF is $206M.
What is Dr. Sulaiman Al Habib's FCF margin?Dr. Sulaiman Al Habib's last 12 months FCF margin is 5%.
What is the current EV/FCF multiple of Dr. Sulaiman Al Habib?Current FCF multiple of Dr. Sulaiman Al Habib is 108.1x.
How many companies Dr. Sulaiman Al Habib has acquired to date?Dr. Sulaiman Al Habib hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Dr. Sulaiman Al Habib has invested to date?Dr. Sulaiman Al Habib hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Dr. Sulaiman Al Habib

Lists including Dr. Sulaiman Al Habib

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial